🟢 Pacific Biosciences is trading 5.7% up; no clear catalyst identified

Pacific Biosciences is trading 5.7% higher at $1.81 on September 29, 2026, with no new company-specific announcement identified to explain the move.

• A possible recent catalyst is Sampled’s September 28 announcement of a five-year VA contract worth up to $27.1 million for genomics work using PacBio Revio systems; coverage linked it to the prior session’s rise.
• Broader indices are modestly lower, offering no clear explanation for today’s gain.